← Back to headlines
Oddity Therapeutics Reports Strong Q2 Results, Driving Share Price Surge
The biotechnology company exceeded second-quarter earnings estimates during its investor call, leading to a 34% jump in its stock price following the release of positive financial metrics.
9 Sept, 13:12 — 9 Sept, 13:12
Sources
Showing 1 of 1 sources
